Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study

Alette H. Ruarus,Laurien G. P. H. Vroomen,Bart Geboers,Eran van Veldhuisen,Robbert S. Puijk,Sanne Nieuwenhuizen,Marc G. Besselink,B.M. Zonderhuis,Geert Kazemier,Tanja D. de Gruijl,Krijn P. van Lienden,Jan J.J. de Vries,Hester J. Scheffer,Martijn R. Meijerink

Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study

2019

Alette H. Ruarus
Laurien G. P. H. Vroomen
Bart Geboers
Eran van Veldhuisen
Robbert S. Puijk
Sanne Nieuwenhuizen
Marc G. Besselink
B.M. Zonderhuis
Geert Kazemier
Tanja D. de Gruijl
Krijn P. van Lienden
Jan J.J. de Vries
Hester J. Scheffer
Martijn R. Meijerink

Percutaneous irreversible electroporation in patients with locally advanced and recurrent pancreatic cancer seems to prolong survival (median overall survival, 17 months) compared with standard of ...

Keywords:

Phases of clinical research
Radiology
Recurrent pancreatic cancer
Medicine
Percutaneous
Irreversible electroporation
overall survival
in patient
locally advanced

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations